March 31, 2017

Walgreens Boots Alliance is reportedly setting a deadline on its $9.7 billion proposed merger with Rite Aid through a declaration of “certified compliance” with Federal Trade Commission.

March 20, 2017

Since becoming a partner in 1994, Rite Aid has raised nearly $81 million, including $6 million in 2016, for Children's Miracle Network Hospitals.

March 15, 2017

MMR vaccinations are available upon request at Rite Aid pharmacies in 28 states and the District of Columbia, subject to state regulations, during pharmacy hours. No appointment is necessary.

March 14, 2017

Fred’s could purchase additional stores, distribution centers, software and personnel, according to a news report.

March 10, 2017

Albertsons, Rite Aid, CVS, Walgreens and Walmart all saw significant rises in year-over-year satisfaction, with all advancing at least 3% year over year, according to the American Customer Satisfaction Index.

March 8, 2017
Wall Street investors have faith that the Federal Trade Commission will approve Walgreens Boots Alliance’s proposed acquisition of Rite Aid — and that’s having a positive influence on Walgreens’ stock, according to Crain’s Chicago Business. WBA’s shares have been up 6% this year and up 19% over March 2016, which Morningstar analyst Vishnu Lekraj says is due to “investor optimism that they’re going to be able to close the Rite Aid transaction.” (Crain’s Chicago Business)
 
March 7, 2017

Walgreens reportedly is weighing whether or not to declare that its FTC application has "certified compliance," which would force the Federal Trade Commission to vote on its proposed acquisition of Rite Aid quickly.

March 6, 2017

DSN examines chain pharmacy, including in-depth coverage of the specialty market, in this multi-page report.

March 6, 2017

Quri recently shared the results of its study examining the importance of continuous in-store merchandising execution data in helping health and beauty brands drive increased return on investment during awards season. 

February 27, 2017

Patient feedback at the convenient care clinics in New Jersey has been excellent, RediClinic CEO Web Golinkin told Drug Store News.

February 16, 2017

The number of stores to be divested to Fred’s Pharmacy was reportedly a big sticking point, but has now been resolved.

February 15, 2017

Greenlight Capital’s David Einhorn reportedly initiates position with 1.5 million Fred’s Pharmacy shares and ups Rite Aid stake to nearly 20.5 million shares in the fourth quarter.

February 15, 2017

Naloxone is also available for purchase without patient specific prescriptions at Rite Aid pharmacies in 17 additional states.

February 3, 2017

The National Retail Federation estimates the proposed tax on imports could cost American families as much $1,700 per year.

February 2, 2017

DSN examines what's trending now overall in oral care, as well as in-depth sales activity in the toothbrush and dental floss categories, highlighting new products hitting the beauty aisles.

February 2, 2017

DSN associate editor David Salazar examines the state of the pharmacy industry, including generics, automation and technology, in this multi-page report.

 

February 1, 2017

Rite Aid shelves are lined with a large assortment of classic chocolate hearts, among other seasonal delights, for Valentine's Day.

January 31, 2017

Evercore ISI’s Ross Muken has reiterated his “buy” rating on Walgreens stock.

January 30, 2017

Under the terms of the amendment, Walgreens Boots Alliance will pay a maximum of $7 per share, down from $9 per share, and the end date is extended from Jan. 27 to July 31.

January 27, 2017

Citing sources close to the negotiations, The New York Post on Friday reported that private-equity giant Cerberus Capital may emerge as a possible white knight for Walgreens and Rite Aid by acquiring the 865 stores being divested. "Cerberus had participated in Walgreen’s December auction of the stores in question, losing to a winning bid of $950 million from regional drug chain Fred’s, according to two sources close to the situation," The Post reported. "Walgreens had rejected Cerberus’ bid partly because it was concerned the Federal Trade Commission would not approve a private-equity buyer, according to the sources." Either way, the deal is "not in danger of collapsing" even though the deal technically expires Friday, The Post added. (The New York Post)

January 26, 2017

If the Walgreens-Rite Aid deal is not extended, Walgreens may need to forfeit a $325 million termination fee, analysts noted.

January 26, 2017

"At this time, we are actively engaged in discussion with Rite Aid regarding how to proceed," Walgreens Boots Alliance CEO Stefano Pessina told shareholders. "These discussions include taking into account anything that is required to gain approval."

January 25, 2017

The New York Post late Tuesday night reported that neither Walgreens nor Rite Aid will the nix the deal if the they don't get regulatory approval by the deadline Jan. 27.  “I assume that is correct,” a source with direct knowledge of the situation told The Post on Tuesday. "Rite Aid’s shares closed up 5 cents, at $6.95, well below the offer price," The Post added. "Its shares could fall below $4 if the deal is blocked, sources said." (The New York Post)

January 23, 2017

"As the Walgreens/Rite Aid merger agreement is set to expire on Jan. 27, Walgreens could look to re-cut the ... deal given the challenges, potentially enhancing its profile," noted DB analyst George Hill.